Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
A vaccine composed of Streptococcus pneumoniae capsular polysaccharides covalently linked to CRM197 carrier protein. This conjugate elicits a T cell-dependent immune response, leading to robust antibody production, immunological memory, and protection against pneumococcal disease.
Induction of T cell-dependent antibody response against Streptococcus pneumoniae capsular polysaccharides via B cell presentation of CRM197-derived peptides to T helper cells, leading to B cell activation, class switching, affinity maturation, and memory cell formation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Streptococcus pneumoniae Capsular Polysaccharide-CRM197 Conjugate (Pn CPS-CRM197 Conjugate).